Status
Conditions
Treatments
About
The objective of this study is to evaluate the product performance of a new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens, when worn by current soft contact lens wearers on a daily disposable wear basis
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Subjects participating in any drug or device clinical investigation within 30 days prior to entry into this study and/or plan to do so during the period of study participation
Subjects who are women of childbearing potential (those who are not surgically sterilized or postmenopausal) are excluded from participation in the investigation if they meet any one of the following conditions:
Subjects with any systemic disease currently affecting ocular health or that, in the Investigator's opinion, may have an effect on ocular health during the course of the study
Subjects with an active ocular disease
Subjects who have had any corneal surgery (e.g., refractive surgery)
Subjects who have worn gas-permeable (GP) contact lenses within the last 30 days or who have worn polymethylmethacrylate (PMMA) lenses within the last 3 months
Subjects who currently wear monovision or toric contact lenses
Subjects who are not correctable to 32 letters (0.3 logMAR) with bilateral soft multifocal contact lenses
Subjects with an ocular astigmatism >1.00 D in either eye
Subjects with anisometropia (spherical equivalent) >2.00 D
Subjects with any Grade ≥2 finding during the slit lamp examination. Subjects with corneal infiltrates of ANY GRADE are not eligible
Any "Present" finding during the slit lamp examination that, in the Investigator's opinion, interferes with contact lens wear
Any scar or neovascularization within the central 6 mm of the cornea. Subjects with minor peripheral corneal scarring (that does not extend into the central area) that, in the Investigator's opinion, does not interfere with contact lens wear are eligible for this study
Subjects who are amblyopic
Subjects using any systemic or topical ocular medication that will, in the Investigator's opinion, affect ocular physiology or lens performance
Subjects who are allergic to any component in the study care products
Primary purpose
Allocation
Interventional model
Masking
301 participants in 1 patient group
Loading...
Central trial contact
Dan Donatello
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal